Solid Biosciences Inc. is a Strong Buy driven by positive FDA alignment on phase 3 IMPACT DUCHENNE trial for SGT-003. Read more on SLDB stock here.

The high-stakes January 2026 Non-Farm Payrolls (NFP) report, now set for release on February 11, 2026, has a consensus ...

The consolidation of SpaceX and xAI could lead to more adaptive use of robots, data, and AI in manufacturing, says ...

On a simple math task - indicating which of two amounts is greater - kids with math learning disability get the right answer ...

With a clutch of key data and planned regulatory applications this year from Avidity Biosciences, REGENXBIO and Capricor ...

While many laptops with comparable CPU specifications are either significantly heavier or have plastic cases, the Geekbook ...

Highline Internet reports that smart home devices consume bandwidth even when idle, impacting internet speed; solutions ...

After years of work building an exquisitely sensitive instrument, University of Chicago scientists stood and watched as it flew up and out of sight into the fiercely blue Antarctic sky. Launched on ...

ICE has used Mobile Fortify to identify immigrants and citizens alike over 100,000 times, by one estimate. It wasn't built to ...

SENITRON announces the release of an operational framework titled Infant Security 2.0, documenting a structured model for ...

SK hynix’s plan to set up an artificial intelligence (AI) solutions firm in the United States is raising questions about how ...

SAG-AFTRA’s tiered agreements are often the first point of union contact for indie filmmakers. They offer lower-budget ...